These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 37567900)
1. Development of novel SARS-CoV-2 viral vectors. Liu H; Liu D Sci Rep; 2023 Aug; 13(1):13053. PubMed ID: 37567900 [TBL] [Abstract][Full Text] [Related]
3. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729 [TBL] [Abstract][Full Text] [Related]
4. A new screening system for entry inhibitors based on cell-to-cell transmitted syncytia formation mediated by self-propagating hybrid VEEV-SARS-CoV-2 replicon. Li N; Chen XL; Li Q; Zhang ZR; Deng CL; Zhang B; Li XD; Ye HQ Emerg Microbes Infect; 2022 Dec; 11(1):465-476. PubMed ID: 35034586 [TBL] [Abstract][Full Text] [Related]
5. The efficient packaging of Venezuelan equine encephalitis virus-specific RNAs into viral particles is determined by nsP1-3 synthesis. Volkova E; Gorchakov R; Frolov I Virology; 2006 Jan; 344(2):315-27. PubMed ID: 16239019 [TBL] [Abstract][Full Text] [Related]
6. Development of a Single-Cycle Infectious SARS-CoV-2 Virus Replicon Particle System for Use in Biosafety Level 2 Laboratories. Malicoat J; Manivasagam S; Zuñiga S; Sola I; McCabe D; Rong L; Perlman S; Enjuanes L; Manicassamy B J Virol; 2022 Feb; 96(3):e0183721. PubMed ID: 34851142 [TBL] [Abstract][Full Text] [Related]
8. Inhibitors of Venezuelan Equine Encephalitis Virus Identified Based on Host Interaction Partners of Viral Non-Structural Protein 3. Bakovic A; Bhalla N; Alem F; Campbell C; Zhou W; Narayanan A Viruses; 2021 Aug; 13(8):. PubMed ID: 34452398 [TBL] [Abstract][Full Text] [Related]
9. Development of a hybrid alphavirus-SARS-CoV-2 pseudovirion for rapid quantification of neutralization antibodies and antiviral drugs. Hetrick B; Chilin LD; He S; Dabbagh D; Alem F; Narayanan A; Luchini A; Li T; Liu X; Copeland J; Pak A; Cunningham T; Liotta L; Petricoin EF; Andalibi A; Wu Y Cell Rep Methods; 2022 Mar; 2(3):100181. PubMed ID: 35229082 [TBL] [Abstract][Full Text] [Related]
10. Ablation of Programmed -1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity. Kendra JA; de la Fuente C; Brahms A; Woodson C; Bell TM; Chen B; Khan YA; Jacobs JL; Kehn-Hall K; Dinman JD J Virol; 2017 Feb; 91(3):. PubMed ID: 27852852 [TBL] [Abstract][Full Text] [Related]
11. Discovery of a novel compound with anti-venezuelan equine encephalitis virus activity that targets the nonstructural protein 2. Chung DH; Jonsson CB; Tower NA; Chu YK; Sahin E; Golden JE; Noah JW; Schroeder CE; Sotsky JB; Sosa MI; Cramer DE; McKellip SN; Rasmussen L; White EL; Schmaljohn CS; Julander JG; Smith JM; Filone CM; Connor JH; Sakurai Y; Davey RA PLoS Pathog; 2014 Jun; 10(6):e1004213. PubMed ID: 24967809 [TBL] [Abstract][Full Text] [Related]
12. Interplay of acute and persistent infections caused by Venezuelan equine encephalitis virus encoding mutated capsid protein. Atasheva S; Krendelchtchikova V; Liopo A; Frolova E; Frolov I J Virol; 2010 Oct; 84(19):10004-15. PubMed ID: 20668087 [TBL] [Abstract][Full Text] [Related]
13. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses. Paessler S; Ni H; Petrakova O; Fayzulin RZ; Yun N; Anishchenko M; Weaver SC; Frolov I J Virol; 2006 Mar; 80(6):2784-96. PubMed ID: 16501087 [TBL] [Abstract][Full Text] [Related]
14. Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function Studies. Nguyen HT; Falzarano D; Gerdts V; Liu Q J Virol; 2021 Aug; 95(18):e0068721. PubMed ID: 34191580 [TBL] [Abstract][Full Text] [Related]
15. Emergence and Magnitude of ML336 Resistance in Venezuelan Equine Encephalitis Virus Depend on the Microenvironment. Lee J; Parvathareddy J; Yang D; Bansal S; O'Connell K; Golden JE; Jonsson CB J Virol; 2020 Oct; 94(22):. PubMed ID: 32878897 [TBL] [Abstract][Full Text] [Related]
16. Pseudotyped viruses permit rapid detection of neutralizing antibodies in human and equine serum against Venezuelan equine encephalitis virus. Kolokoltsov AA; Wang E; Colpitts TM; Weaver SC; Davey RA Am J Trop Med Hyg; 2006 Oct; 75(4):702-9. PubMed ID: 17038698 [TBL] [Abstract][Full Text] [Related]
17. A roadmap for developing Venezuelan equine encephalitis virus (VEEV) vaccines: Lessons from the past, strategies for the future. Han L; Song S; Feng H; Ma J; Wei W; Si F Int J Biol Macromol; 2023 Aug; 245():125514. PubMed ID: 37353130 [TBL] [Abstract][Full Text] [Related]
18. Benzamidine ML336 inhibits plus and minus strand RNA synthesis of Venezuelan equine encephalitis virus without affecting host RNA production. Skidmore AM; Adcock RS; Jonsson CB; Golden JE; Chung DH Antiviral Res; 2020 Feb; 174():104674. PubMed ID: 31816348 [TBL] [Abstract][Full Text] [Related]